Lazard Capital Starts Nektar Therapeutics (NKTR) at Buy

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/19/2026

1. NVDA
2. DOO
3. HD
4. AMLX
5. METC
6. SPY
7. ARGX
8. KLAR
9. INFQ

January 15, 2013 6:44 AM EST
Get Alerts NKTR Hot Sheet
Price: $73.64 --0%

Rating Summary:
    20 Buy, 7 Hold, 5 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 5 | Down: 6 | New: 5
Join SI Premium – FREE
Lazard Capital initiates coverage on Nektar Therapeutics (NASDAQ: NKTR) with a Buy. PT $15.00.

For an analyst ratings summary and ratings history on Nektar Therapeutics click here. For more ratings news on Nektar Therapeutics click here.

Shares of Nektar Therapeutics closed at $8.74 yesterday.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

New Coverage

Related Entities

Lazard